@~~

Divi's Laboratories Limited

Date. 5 th February 2016

The Secretary

BSE Limited

1st Floor, New Trading Ring, Rotunda Bldg.,

PJ. Towers, Dalal Street, Fort

MUMBAI - 400 023

Dear Ir,

Sub: Un-audited financial results for the quarter and nine months ended
31 st December 2015 and limited review report -reg
Ref: Stock code: 532488
Pursuant to Regulation 33 of

' . . B[ (Listing Obligations and Disclosure

Requirements) Regulation, 2015, please find enclosed un-audited financial results

along with the limited review report [or the quarter and nine months ended 31 5t
Dec mber 2015.
Above un-aud ited financials were approved and taken on record by the Board of
Directors o[the Company at their meeting held on Friday, 5th February 20 16.
The Company proposes release of press note as per the enclosed format. This is
for your information and r cords. Kindly acknowledge the receipt of the same.
Thanking You,
Yours faithfully,

For Divi's Laboratories Limited

i2. '
L-
P V ~C>a~shmi Rajani

.""IoJ

Company Secretary

(ACS 18882)

CIN : L2411 OTG 1990PLC011854

"An ISO-9001, 150-14001 and OHSAS-18001 Triple certified company"

Regd. Off: Divi Towers, 7-1-771Fl1/303, Dharam Karan Road, Ameerpet, Hyderabad - 500 016. INDIA

Tel: 91-40-23786300, Fax: 91-40-2378 6460

E-mail: mail@divislabomtories.com, Website: www.divislabomtories.com

DIVI'S LABORATORIES LIMITED

UN-AUDIl ED FINA CIAL RESULTS (Sr ANDA LONE )
FOR TILE QUARTER A D NINE ONTIIS ENDED 31" DECEMBER. 20 15

(Rs.in Lakbs)
Particulars

Quarter ended

(I )
I

Income from operations

(a) Net Sales/Income from
o[lerations (Net of Excise Dul)')
(b) Other Operat ing Income
Total rncome from operations
(net)
Expenses

a. Cost o f materials consumed

h. Purchases of stock-in-trade
c. Changes in in ven t ries of
l1 nished good " work-i n
progress and slock-in-trade
d. Emplo ee benetits expense
c. Depreciation and amortizatio n
expense
r. Other Expenses
Total Expenses

4
5

8
\}

Profit from Operations before

Olher Income, Finance Costs &
Exceptional Items (1-2)
Other Income
Pro lit from ordinary activities
before flnnnce costs & exceptional
Uems (3+4)
r inant:e Costs
Prolit from ordinary activities
after linance costs but before
exceptionnlltems (5-6)
Exc\![lliona l items
Profit from ordinary activities
before Tax (7-8)

10

rax Expense

II

Net Profit from ordinary activitie

after Tax (9- 10)
E'lra-ordinary itcms (net of tax
expcnse)
Net Profit (+)/Loss(-) for the
period (11-12)
Pai d-u p Equity Share Capital
(face Value : Rs.2 per share)

12

13
14

STANDALONE
Nine Monlhs ended

31.12.2015

30.09.2015

31.12.20 14

31.12.2015

31.12.2014

Year
Ended
31.03.2015

Unaudited
(2)

Unaudited
(3 )

Unaud ited

Unaudited

(4)

(5)

Unaudited
(6)

Audited
(7)

85177

96187

78808

262055

225 761

307230

110
85287

245
96432

304
79 112

540
262595

93J
226692

1171
308401

33258
0
(1512)

42106

34672

105441

(3571 )

(2808)

110931
0
(8596)

144627
0
(23083)

9118
2988

8595
3007

7459
2879

25746
8887

20425
9131

283 15
13585

12194
56046
29241

11702
61839
34593

11080
53282
25830

34700
]71668
90927

31546
152917
73775

42337
205781
102620

1520
30761

2964

37557

1994
27824

7883
98810

481 7
78592

4284
106904

23
30738

34
37523

48
27776

79
98731

1. 27
78465

186
106718

0
30738

0
37523

0
27776

0
98731

0
78465

0
106718

6082
24656

7950
295 73

5718
22058

20184
78547

16650
61815

22012
84706

24656

29573

22058

78547

61815

84706

5309

5309

2655

5309

2655

2655

( 13626)

15
16

Reserves excluding revaluation

rese rves as per balance sheet of
previous accounting year
Earnings per Share
(of Rs.21- each) (not annualized):
a) Basic
b) Diluted

35354 1
9.29
9.29

11. 14
1 1. 14

8.3 1
8.3 1

29.59
29.59

23.29
23.29

31.91
3 1.9 1

NOTES:

I . The above results for the quarter ended 31 '1Dece mber 2015, as reviewed by the Audit Comm ittee, were considered and
approved by the Board of Directors at its meeting held on Sd1 February, 2016 and were subjected to ' limited review' by
the Auditors.
2. The Company is primarily engaged in the man ufacture of Active Pharmaceutical Ingredients and intennediates.
Accordingly there are no reportable segments as p r Accounting Standard 17 notified under the Compan ies Act, 1956.
3. The company has opted to publish quarter ly unaud ited standalone resul ts and to publish consol idated results at the year
end.
4. Detal'1so f ftorex gam
. /I oss are gIven beow:
I
Rs.m
. L a kh

' s
Quarter
ended
Nine
Months
ended
Particulars
Year
Ended

31.12.20 14
3 1. 12.20 14
31 .03.201 5
31.12.2015
Unaudited
Unaudi ted
Unaudited
Unaudited
Unaudited
Audited
1683
( lOS)
294
1166
1116
3582
For.::x Oain/(Loss)
Forex gam has been mcluded m Other Income and forex loss has been IIlcluded 111 Other Expenses.
5. Bonus Issue: The company has allolled 13,27,34,290 bonus shares of Rs.2 each to the members on 281h September.
2015 . Earnings per Share has bee n adjusted for previous periods presented due to the bonus issue, in accordance with
Accounting Standard No.20 .
6. Upon enactment of the Payment of Bonus (Amend ment) Act, 2015 , the company has made add itional provision for
bonus to employees, during the quart r, amounting to RS.25 7 lakhs for the previous year 20 14- 15.
7. Figures for the previous year/period have been regrouped or reclassified , wherever necessary.
31.12.2015

30.09.2015

Place: Visakhapatnam
Date: 05-02-2016
Chairman & Manag ing Director

P.VR K. Nageswara Rao & Co.,

Chartered Accountants
INDEPENDENT AUDITOR'S REVIEW REPORT

TO
THE BOARD OF DIRECTORS OF
DIVI'S LADORA TORIE LlMlTED
We haw reviewed the accompanying statement of Standalone Unaudited Financia l
Result f D1vr's LABORATORlE LIMITED (.. the company") for the quarter Clnd
s,
nine months ended 31 December, 2015 ("the tatement"). This statement is the
respons ibility of the Company's Managemen t and has been approved by the Board f
Directors. Qur responsibility is to issue a report on the Statement based on our rev iew.
We conducted Ollr review of the Statement in accordance with the Standard on Review
Lngugemen ls (SRE) 241 0, . Review of Interim Financial Informat ion Performed by the
Independen t Auditor of the Entity'. issued by the Institu te of Chartered A(.;cOLll1lanL of
Ind ia. Thi standard requires that we plan and perform the rev iew LO obtain moderat\!
a slirance as to whether the Statement is free of material misstatement. A rev iew is
limited primarily to inquiries of Company personnel and analytical procedures ap plied to
ti ll uncial data and thu provide less assurance than an alldit. We have no t perform ed an
audit andaccordingly, we do not express an audit opin ion.
Based on our review contll! ted as Slated above, nothing has come to ollr allen tio n that
callses liS to believe that the accompanying Statement, prepared in accordance with th~
applicable Accounting Standards and other recog nised accounting practices anu polic ies,
has not di closed the information required to be di closed in terms of Reg ul atio n :1 of lhl:
SEB I (Listing Obligation and Disclosure Requirements) Reg ulations, 2015 inc lud in g thl.!
manner in which it is to be disclosed, or that it contains any materia l misstatement.

For P.V.RK. NAGE WARA RAO & Co.,

VlSAKH APATNAM
05.02.2016

Partner
Membersh ip Number:23939

109, Metro Residency I 6-31247, RaJbhavan Road I Khairatabad, Hyderabad - 500082 I India.

({) Off. . +91-40-23311609, +91-40-23312269 (Oir) I Fax : +91-402331 9591 I E-mail pvrk@pvrk.com

DIVI'S LABORATORIES LIMITED

Hyderabad
PRESS RELEASE dated 5 th February, 2016

Divi's Labs earns a PAT of Rs.247 crores in Q3/FY16

Divi's Laboratories has earned a Profit after Tax (PAT) of Rs.247 crores on
a total income of RS.853 crores, on a stand-a lone basis, for the quarter
ended 31 st December, 2015.

For t he corresponding quarter of the last

year the company earned a PAT of RS.221 crores on a total income of Rs.
79

crores.

Forex gain for the current quarter amounted to Rs.3 crores as against a
forex gain of RS.ll crores during the corresponding quarter last year .
The company has capitalized fixed assets aggregating to RS.34 crores
duri ng the curre nt quarter.

For the 9-month period ended 3pt December, 2015, the company earned
a total income of RS.2626 crores as compared to Rs. 226 7 crores during
the corresponding 9 - month pe riod of last year .

PBT for the current 9

month period came to RS.987 crores as against a PBT of Rs. 785 crores
for the previous period. PAT for the current 9-months is Rs.785 crores as
against Rs. 618 crores for the previous period.